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Succinate dehydrogenase (SDH) occupies a central
place in cellular energy production, linking the tricar-
boxylic cycle with the electron transport chain. As
a result, a subset of cancers and neuromuscular
disorders result from mutations affecting any of the
four SDH structural subunits or either of two known
SDH assembly factors. Herein we characterize an
evolutionarily conserved SDHassembly factor desig-
nated Sdh8/SDHAF4, using yeast, Drosophila, and
mammalian cells. Sdh8 interacts specifically with
the catalytic Sdh1 subunit in the mitochondrial ma-
trix, facilitating its associationwith Sdh2 and the sub-
sequent assembly of the SDH holocomplex. These
roles for Sdh8 are critical for preventing motility
defects and neurodegeneration in Drosophila as
well as the excess ROS generated by free Sdh1.
These studies provide insights into the mechanisms
by which SDH is assembled and raise the possibility
that some forms of neuromuscular disease may be
associated with mutations that affect this SDH as-
sembly factor.
INTRODUCTION
Mitochondria are dynamic organelles that are essential for
many cellular processes including metabolism, signal transduc-
tion, and apoptosis. Consistent with these broad cellular func-
tions, mitochondrial dysfunction is associated with a wide range
of human diseases, including diabetes, neurodegeneration, and
cancer. These important roles have led to comprehensive char-
acterization of themitochondrial proteome, identifyingmore than
1,000 nuclear-encoded proteins (Sickmann et al., 2003; Pa-
gliarini et al., 2008). In spite of these efforts, however, manymito-
chondrial proteins remain uncharacterized, including proteins
that are conserved throughout eukaryotic evolution. We areCelstudying this subset of proteins as part of a systematic effort
to comprehensively understand mitochondrial physiology.
Herein, we describe the function of one of these evolutionarily
conserved proteins and demonstrate that it is essential for
proper succinate dehydrogenase (SDH) complex assembly
and activity in yeast, flies, and mammalian cells.
SDH is unique in that it functions in both the tricarboxylic acid
(TCA) cycle and the electron transport chain (ETC), wherein it is
referred to as Complex II. SDH links the oxidation of succinate
to fumarate in the TCA cycle with the reduction of ubiquinone
to ubiquinol in the ETC, which contributes to the establishment
of the mitochondrial membrane potential and ATP synthesis.
SDH is a heterotetrameric protein complex that is embedded
in the inner mitochondrial membrane (IMM), with its cat-
alytic domain facing the mitochondrial matrix. The complex is
anchored to the IMM by two integral membrane proteins, Sdh3
(SDHC in humans) and Sdh4 (SDHD). The Sdh3/Sdh4 dimer
binds the peripheral membrane protein Sdh2 (SDHB), which
tethers the catalytic Sdh1 (SDHA) subunit to the complex.
Sdh1 harbors a covalently bound FAD cofactor that is required
for the oxidation of succinate (Robinson et al., 1994). The two
electrons that result from succinate oxidation are channeled
through the three iron-sulfur clusters in Sdh2 to ubiquinone,
which interacts with SDH via the Sdh3/Sdh4 membrane anchor
(Rutter et al., 2010).
The assembly of complexes like SDH presents the cell with the
problem of coordinating the synthesis and stepwise interactions
of individual subunits to form an intricate membrane-bound
complex. This problem is exacerbated in the case of ETC com-
plexes, as individual subunits contain redox-active cofactors
that can perform inappropriate and deleterious reactions when
they are not properly secluded within the native complex. As a
result, a number of dedicated factors assist the assembly of
these complexes by facilitating cofactor insertion, preventing
nonproductive interactions, and stabilizing assembly intermedi-
ates. While the importance of assembly factors for Complexes I
and IV are well established (Ferna´ndez-Vizarra et al., 2009; Diaz
et al., 2011), dedicated SDH assembly factors have only recently
begun to emerge with the discovery of SDHAF1 (Sdh6 in yeast)
and SDHAF2 (Sdh5; Ghezzi et al., 2009; Hao et al., 2009). Humanl Metabolism 20, 241–252, August 5, 2014 ª2014 Elsevier Inc. 241
Cell Metabolism
SDHAF4 Functions as an SDH Assembly Factorpatients with loss-of-function mutations in SDHAF1 or SDHAF2
display reduced SDH complex levels and activity and present
with infantile leukoencephalopathy and neuroendocrine tumors,
respectively (Ghezzi et al., 2009; Hao et al., 2009). This is consis-
tent with the spectrum of diseases that associate with mutations
affecting the core subunits of SDH—SDHA, SDHB, SDHC, and
SDHD (Rutter et al., 2010) and with a series of additional dis-
eases that are characterized by loss of SDH activity, but which
lack mutations in known SDH genes (Jain-Ghai et al., 2013).
Disruption of the yeast orthologs for SDHAF1 or SDHAF2
(SDH6 or SDH5) prevents respiratory-dependent growth, with
a clear defect in SDH activity. While the precise mechanism by
which Sdh6 supports SDH biogenesis has remained elusive,
Sdh5 was shown to be required for the covalent attachment
of the FAD cofactor to Sdh1 (Ghezzi et al., 2009; Hao et al.,
2009). The current model proposes that Sdh1 is flavinated by
Sdh5 and binds iron-sulfur-loaded Sdh2, which then docks
onto the preassembled membrane-bound Sdh3-Sdh4 dimer to
form the holocomplex (Rutter et al., 2010). We hypothesized
that the complexity of this assembly process likely necessitates
the action of additional dedicated assembly factors and that the
genes encoding these factors may contribute to the currently
idiopathic SDH-associated genetic diseases.
With the goal of discovering new human disease genes and
gaining a better understanding of SDH assembly and activity,
we have focused on our ongoing functional elucidation of un-
characterized mitochondrial proteins. These studies led us to
identify an evolutionarily conserved SDH assembly factor,
Ybr269, which we have renamed Sdh8 in yeast and SDHAF4 in
higher organisms. Utilizing yeast, flies, and mammalian cells,
we have defined the molecular function of the SDHAF4 protein
family in SDH assembly and an important role for SDHAF4 in
metazoan physiology.
RESULTS
Yeast Sdh8 Is a Conserved Mitochondrial Matrix Protein
Required for Maximal SDH Activity
Sdh8 is a small protein of approximately 15 kDa that belongs to
a pan-eukaryotic protein family, which we have named the
SDHAF4 family (Figure S1A available online). N- and C-terminal
Sdh8 fusion proteins were unable to complement the phenotype
of an sdh8D mutant strain and were therefore deemed to be
nonfunctional. Efficient rescue was seen, however, when either
a tandem affinity tag (His6HA3) or GFP was fused into a pre-
dicted unstructured region within Sdh8, between residues N82
and S83. These constructs, which were subsequently named
Sdh8-His6HA3 and Sdh8-GFP, respectively, were expressed un-
der the control of the native SDH8 promoter and terminator and
determined to be fully functional (See Figures 1A and S1E). As
expected, we found that Sdh8 localizes exclusively to mitochon-
dria and determined it to be a soluble matrix protein (Figures
S1B–S1D). To begin to assess the role of Sdh8 in mitochondrial
function, an sdh8D mutant was established in two strains
(BY4741 and W303), both of which were used for key experi-
ments to control for genetic background. While sdh8D mutants
grew normally in glucose medium, growth was impaired on glyc-
erol and acetate, demonstrating a defect in mitochondrial respi-
ration (Figures 1A and S1E). Interestingly, the growth impairment242 Cell Metabolism 20, 241–252, August 5, 2014 ª2014 Elsevier Incwas exacerbated on acetate-containing medium, which is a hall-
mark of mutants that affect SDH activity. Consistent with this
possibility, metabolomic analysis of sdh8D mutants revealed
an apparent block in the TCA cycle at SDH, with an accumulation
of succinate and depletion of the two TCA cycle intermediates
downstream of SDH: fumarate and malate (Figures 1B and
S1F–S1H). We also measured the enzymatic activity of SDH in
mitochondria harvested from wild-type (WT) and sdh8D cells.
SDH activity in sdh8D cells was decreased 60% relative to WT
(Figure 1C), while malate dehydrogenase (MDH) activity was un-
affected (Figure 1D). Finally, the steady-state level of the SDH
holocomplex was assessed by blue native polyacrylamide gel
electrophoresis (BN-PAGE). Mitochondria purified from either
WT or sdh8D cells were solubilized in digitonin, resolved by
BN-PAGE, and probed by immunoblot. We observed a marked
decrease in assembled SDH and demonstrated that re-expres-
sion of Sdh8-His6HA3 (see Supplemental Information) in sdh8D
cells was sufficient to rescue the defect in SDH assembly (Fig-
ures 1E and S1I). Taken together, these data demonstrate that
Sdh8 is required for the stability and activity of SDH.
As a first step toward determining if its function is conserved
across eukaryotic species, the human and Drosophila orthologs
of SDH8 (SDHAF4 and dSdhaf4, respectively) were expressed in
the sdh8Dmutant under the control of the native SDH8 promoter
and terminator. Both orthologs complement the sdh8D growth
defects (Figure 1F), suggesting that the role of Sdh8 in SDH
assembly is an evolutionarily conserved feature of the SDHAF4
family.
Mammalian SDHAF4 Is Required for Maximal SDH
Activity
To assess a possible role for mammalian SDHAF4 in SDH func-
tion, we transfected C2C12 mouse myoblasts with a nontarget-
ing control siRNA (control) or either of two siRNAs targeting
mouse SDHAF4 (si1 and si2). Knockdown of SDHAF4 mRNA
was confirmed (Figure 2A), and mitochondria were harvested
from cells transfected with control, si1, and si2 siRNAs. Immuno-
blot of the isolated mitochondria revealed that depletion of
SDHAF4 did not affect the steady-state abundance of SDHA or
SDHB (Figure S2A). We detected, however, a decrease in SDH
enzymatic activity in SDHAF4 knockdown cells (Figure 2B) with
no significant change in MDH activity (Figure S2B). In addition,
cells transfected with si1 or si2 showed a reproducible and spe-
cific decrease in steady-state SDH complexes as assayed by
BN-PAGE of amagnitude similar to that seen in SDH activity (Fig-
ure 2C). We conclude that SDHAF4 is required for the proper as-
sembly and activity of SDH in both yeast and mammalian cells.
Drosophila Sdhaf4 Is Required for Maximal SDH Activity
To further define the function of Sdh8 in a multicellular organism,
we extended our analysis to Drosophila. Three null alleles were
generated in the Drosophila ortholog of SDH8 (CG7224) that
we have renamed Drosophila Sdhaf4 (dSdhaf4) (Figure S3A).
Similar to our findings in yeast, metabolomic analysis of dSdhaf4
mutants compared to genetically matched controls revealed a
significant accumulation of succinate and depletion of malate
and fumarate (Figure 3A). Acetyl-CoA was also elevated, while
citrate and isocitrate were reduced in the mutants (Figure 3A).
These effects may be due to a reduction in oxaloacetate that is.
Figure 1. Yeast Sdh8 Is a Conserved Mitochondrial Matrix Protein Required for Maximal SDH Activity and Assembly
(A) Ten-fold serial dilutions of WT yeast transformed with an empty vector (EV) or sdh8D mutants transformed with either EV or a plasmid expressing
SDH8-His6HA3, all in a BY4741 background.
(B) GC/MS was used to measure the abundance of metabolites in WT and sdh8D yeast (BY4741 background. n = 6 biological replicates. ****p < 0.0001;
**p < 0.005; *p < 0.05).
(C and D) (C) SDH and (D) MDH enzyme assays were performed on mitochondrial extracts of WT, sdh8D, and sdh1D strains, normalized to total protein (±SEM.
n = 3 biological replicates. **p < 0.005).
(E) WT and sdh8D mitochondria were solubilized in digitonin, fractionated by BN-PAGE, and analyzed by immunoblotting to detect Atp2 (complex V), Cor1/2
(complex III), Cox3 (complex IV), Sdh1 (complex II), or Porin.
(F) Ten-fold serial dilutions of the indicated strains were grown as in (A). SDHAF4 and dSdhaf4 are the human andDrosophila orthologs of SDH8, respectively, and
were each expressed under the control of the endogenous SDH8 promoter and terminator.
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Figure 2. Mammalian SDHAF4 Is Required for Maximal SDH Activity
(A) C2C12 cells were transfected with either a control nontargeting siRNA or
either of two siRNAs directed against SDHAF4 (si1 and si2), and SDHAF4
mRNA abundance was assayed by quantitative RT-PCR and normalized to
tubulin mRNA (±SEM. n = 3 biological replicates. ***p < 0.0005).
(B) SDH enzyme activity was measured in mitochondria harvested from
C2C12 cells treated as in (A) (±SEM. n = 3 biological replicates. ***p < 0.0005;
*p < 0.05).
(C) Mitochondria extracted from C2C12 cells treated as in (A) were solubilized
in digitonin, fractionated by BN-PAGE, and analyzed by immunoblotting for
ATP5A (complex Vmonomers [CVI] or dimers [CVII], QCR2 [complex III], VDAC,
or SDHA [complex II]).
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with this, aspartate, which is interconvertible with oxaloacetate,
is depleted in dSdhaf4 mutants (Figure S3C). Similar changes
were observed upon metabolomic analysis of flies carrying a
dSdhaf4 TALEN-induced allele over an independently derived
imprecise excision, indicating that these results remain constant
across genetic backgrounds (Figures S3B and S3C). Consistent
with this metabolomic profile, dSdhaf4 mutant mitochondria
displayed an 85% reduction in SDH activity (Figure 3B) while
citrate synthase (CS) activity was unaffected (Figure 3C). Based
on these data, we conclude that, like yeast sdh8D mutants,
dSdhaf4 mutants have a specific impairment in SDH function.
Drosophila Sdhaf4 Is Required for the Stability of SdhA
and SdhB
The decrease in SDH activity in dSdhaf4mutants is greater than
that seen in yeast sdh8D mutants, suggesting that there might
be a more profound effect on the steady-state level of SDH.
Consistent with this, the SDH holocomplex was undetectable
by BN-PAGE, whereas the levels of Complex V were unaffected
(Figure 4A). This lack of SDH holocomplex was accompanied by
an apparent reduction in the stability of the SdhA and SdhB sub-
units in dSdhaf4mutants (Figures 4B, S4A, and S4B). In contrast,
dSdhaf4 heterozygous mutants displayed similar SDH activity
to controls (Figure S4C), and dSdhaf4 overexpression had no
effect on SDH activity or SDH subunit protein levels (Figures
S4D and S4E).
The reduced levels of SDH subunits in the dSdhaf4 mutant
suggest that wemight see genetic interactions between dSdhaf4
alleles and mutations in SDH subunit-encoding genes. Consis-
tent with this, we found that dSdhaf4 mutant flies heterozygous244 Cell Metabolism 20, 241–252, August 5, 2014 ª2014 Elsevier Incfor a strong loss-of-function mutation in SdhA or homozygous
for a hypomorphic mutation in SdhB displayed reduced viability
compared to controls (Figures 4C and S4F). This genetic interac-
tion is specific for SDH subunit-encoding genes, as dSdhaf4
mutants heterozygous for a null allele of CoVa (Mandal et al.,
2005) displayed normal viability (Figure 4C). Taken together,
these biochemical and genetic studies indicate that dSdhaf4 is
required for SDH assembly and activity.
dSdhaf4Mutants Display Neurodegeneration,
Early-Adult Lethality, and Sensitivity to Oxidative Stress
Consistent with their metabolic defects, dSdhaf4 mutants
died significantly earlier than controls, with a median lifespan
of 12 days compared to a median lifespan of 69 days for control
flies (Figure 5A). Interestingly, these mutants also displayed two
phenotypes that are hallmarks of mitochondrial dysfunction:
bang sensitivity and erect wings (Figures 5B, 5C, S5A, and
S5B) (Greene et al., 2003; Fergestad et al., 2006). In addition,
dSdhaf4 mutant retinas displayed a marked disorganization of
retinal architecture (Figure 5D, asterisks), consistent with the
known association between bang sensitivity and neurodegener-
ation (Celotto et al., 2006a; Gnerer et al., 2006; Liu et al.,
2007). The photoreceptors were also highly vesicularized (Fig-
ure 5D, arrows) (Kiselev et al., 2000), with aberrant mitochondrial
morphology (Figure 5D, arrowheads). The bang sensitivity of
dSdhaf4 mutants can be rescued by specific expression of WT
dSdhaf4 in neurons, suggesting that it is associatedwith the neu-
rodegeneration (Figures 5E, S5C, and S5D). Moreover, global
expression of human Sdhaf4 in dSdhaf4 mutants partially
rescued the bang-sensitivity of these animals, providing further
evidence of a conserved function for Sdhaf4 (Figures 5E, S5C,
and S5D). Taken together, these results demonstrate that
dSdhaf4 is required in neurons to maintain tissue architecture
and function.
Defects in mitochondrial ATP production and reactive oxygen
species (ROS) homeostasis have been previously shown to
cause neurodegenerative phenotypes similar to those observed
in dSdhaf4 mutants (Fergestad et al., 2006; Liu et al., 2007;
Celotto et al., 2012). Since loss of dSdhaf4 does not appear to
affect steady state ATP levels (Figures 3A and S3B), we hypoth-
esized that dSdhaf4 may be required to protect against ROS
toxicity. Consistent with this, dSdhaf4 mutants were highly sen-
sitive to oxidative stress induced by hyperoxia (Figure 5F) but
showed no sensitivity to starvation, which is unassociated with
ROS production (Figure S5E). These data suggest a connection
between the role of dSdhaf4 in SDH assembly and oxidative
stress resistance.
Yeast Sdh8 Is a Chaperone for Soluble and Covalently
Flavinated Sdh1
Data from three distinct eukaryotic systems indicate that the
SDHAF4 protein family plays an evolutionarily conserved role
in SDH assembly and activity. Turning back to yeast, we sought
to understand the mechanism by which Sdh8 supports SDH
biogenesis. To identify proteins interacting with Sdh8, we per-
formed a large-scale HA immunoprecipitation from either WT
or Sdh8-His6HA3 containing mitochondria. The final eluates
were resolved by SDS-PAGE, revealing a band of 70 kDa
that was present only in the Sdh8-His6HA3 immunoprecipitation..
Figure 3. Drosophila Sdhaf4 Is Required for
SDH Activity
(A) Either LC/MS (acetyl-CoA, succinyl-CoA, ATP,
AMP, NAD, NADH, NADP, and NADPH) or GC/MS
(citrate, isocitrate, alpha-ketoglutarate, succinate,
fumarate, and malate) was used to measure the
abundance of metabolites in trans-heterozygous
dSdhaf41/2 (dSdhaf4) mutants compared to
genetically matched w1118 controls (dSdhaf4+).
Eight to twelve biological replicates from two
independent experiments were combined per
genotype.
(B and C) (B) SDH or (C) CS enzymatic activity was
measured in extracts from mitochondria isolated
from either control or dSdhaf4 mutant flies
(±SEM. n = 4–6 biological replicates. **p < 0.01 and
***p < 0.001). Two independent experiments were
performed with similar results.
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Sdh1, the catalytic subunit of SDH (Figure S6A). The putative
Sdh8/Sdh1 interaction was confirmed by immunoprecipitation
of Sdh8 followed by identification of Sdh1 in the eluate using
an Sdh1-specific antibody (Figure 6A, lanes 1 and 6 versus 2
and 7). Interestingly, it appears that Sdh2 is not a member of
this complex as it is undetectable in the eluate (Figure 6A).
Since Sdh8 binds Sdh1 independent of Sdh2, we hypothe-
sized that Sdh8 may be acting as a chaperone for a free solubleCell Metabolism 20, 241–2pool of Sdh1 in the mitochondrial matrix.
If this is true, then deletion of SDH2 might
shift Sdh1 to a free soluble form, which
would increase the demand for Sdh8
function. Consistent with this possibility,
sdh2D mutant mitochondria exhibit
an accumulation of Sdh8-His6HA3 (Fig-
ure 6B, lane 1 versus 3), while sdh1D
mutant mitochondria exhibit a depletion
of Sdh8-His6HA3 (Figure 6B, lane 1 versus
2). Furthermore, this accumulation of
Sdh8-His6HA3 results in enhanced Sdh1-
Sdh8 association in the sdh2D mutant
(Figure 6A, lanes 2 and 7 versus 3 and 8)
despite an approximately 2-fold decrease
in steady-state Sdh1 levels (Figure 6B,
lane 1 versus 3).
Although the stability of Sdh8 depends
on Sdh1, Sdh1 abundance is unaffected
by the deletion of SDH8 (Figure 6B, lane
1 versus 4). However, Sdh2 levels are
reduced in an sdh8D mutant, likely due
to decreased Sdh1 competence for inter-
action with Sdh2 (Figure 6B, lane 1 versus
4). This is further supported by the obser-
vation that the formation of the Sdh1-
Sdh2 soluble dimer, which is readily
apparent in a mutant lacking the Sdh4
membrane anchor, is impaired in an
sdh8D mutant (Figure S6F). Interpretation
of this experiment is complicated by thedecreased Sdh2 steady-state level in the sdh8D mutant, but
the data are most consistent with the hypothesis that Sdh8 is
required to maintain Sdh1 in a state that is fully competent to
bind Sdh2 and assemble in the SDH holocomplex.
Sdh1 is known to be covalently flavinated at H90 in a reaction
that requires the activity of Sdh5 (Hao et al., 2009). Initially, we
found that deletion of SDH8 does not impact the flavination of
Sdh1 (Figure S6B). We reasoned, however, that Sdh8 might
act specifically on the flavinated form of free Sdh1. Accordingly,52, August 5, 2014 ª2014 Elsevier Inc. 245
Figure 4. Drosophila Sdhaf4 Is Required for SdhA and SdhB Stability
(A) Mitochondrial extracts from either w1118 controls (dSdhaf4+) or dSdhaf41/2
mutants (dSdhaf4) were fractionated by BN-PAGE and analyzed by immu-
noblotting to detect Atpa (Complex V) or SdhB (Complex II).
(B) Total protein from mitochondria isolated from either control or dSdhaf4
mutant flies was resolved using SDS-PAGE, followed by immunoblotting to
detect SdhA, SdhB, or Atpa.
(C) Flies carrying either control or dSdhaf4 mutant chromosomes over a bal-
ancer chromosome were crossed to flies carrying a strong loss-of-function
allele for either SdhA or Cytochrome c oxidase Va subunit (CoVa) over a bal-
ancer. The resulting progeny were scored for the absence or presence of the
marker linked to the balancer chromosome. The proportion of the expected
progeny that eclosed, based on Mendelian ratios of the indicated genotypes,
is shown. (±SEM. n = number of progeny assayed from each cross. ***p <
0.001 (Student’s t test).
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express WT Sdh1, Sdh1H90A, or Sdh1H90S, which are Sdh1 mu-
tants that cannot covalently bind FAD. Indeed, Sdh1H90A and
Sdh1H90S both failed to copurify with Sdh8-His6HA3 (Figures
6A, lanes 2 and 7 versus 4 and 9, and S6C), even in the absence
of Sdh2 (Figure 6A, lanes 3 and 8 versus 5 and 10). In further sup-
port of this hypothesis, we found that Sdh1 failed to interact with
Sdh8-His6HA3 in sdh5Dmutant cells (Figure S6D), which lack co-
valent Sdh1 flavination (Figure S6B) (Hao et al., 2009). Further-
more, Sdh8-His6HA3 was destabilized in the sdh5D mutant as
was observed for the sdh1Dmutant (Figure S6E, lane 1 versus 6).
Finally, Sdh8-His6HA3 is not present in the SDH holocomplex,
as assayed by BN-PAGE (Figure 6C, lane 1). We also observed
that deletion of SDH2 or SDH4, which ablates the SDH holocom-
plex, causes the emergence of a subcomplex of 150 kDa,
which lacks Sdh2 but clearly contains both Sdh1 and Sdh8 (Fig-
ure 6C, lanes 2 and 5). This is not coincidental comigration as246 Cell Metabolism 20, 241–252, August 5, 2014 ª2014 Elsevier Incloss of either Sdh1 or Sdh8 causes this subcomplex to disappear
from sdh2D and sdh4D mutant strains (Figure 6C, lanes 3, 4, 6,
and 7). The Sdh1-Sdh8 subcomplex can also be detected in
WT cells, albeit at lower steady-state levels than in sdh2D and
sdh4Dmutants (Figure S6G). Taken together, these data demon-
strate that Sdh8 interacts specifically with flavo-Sdh1, indepen-
dent of other components of the SDH complex, and its stability
depends upon this interaction.
Sdh8 Protects the Cell from Oxidative Stress
The data presented thus far demonstrate that Sdh8 acts as a
chaperone for Sdh1 to promote formation of the Sdh1-Sdh2
dimer. We found that overexpression of Sdh1 does not rescue
the growth defects of sdh8D mutants but, rather, is toxic to
both WT and sdh8D cells on respiratory carbon sources, with
the sdh8D mutant being particularly sensitive (Figures 7A and
S7A). This observation raises the possibility that free Sdh1 is
toxic and that Sdh8 may alleviate this toxicity. To test this, we
co-overexpressed Sdh8 with Sdh1 and observed a significant
rescue of the Sdh1 toxicity in WT cells (Figure 7B). We conclude
that, in addition to promoting assembly of the Sdh1-Sdh2 dimer,
Sdh8 also prevents the toxicity associated with free Sdh1.
In considering possible mechanisms for toxicity of free Sdh1,
we hypothesized that the exacerbated sdh8D phenotype on ac-
etate compared to glycerol medium (Figure 1A) may be the result
of increased oxidative stress. This is consistent with previous re-
ports using acetate to trigger ROS-dependent cell death in yeast
(Carmona-Gutierrez et al., 2010), as well as the sensitivity of
dSdhaf4 mutant to hyperoxia (Figure 5F). In support of this
hypothesis, we found that the sdh8Dmutant is profoundly hyper-
sensitive to paraquat in glycerol media relative to WT cells (Fig-
ure 7C). To test this hypothesis directly, we sought to quantify
the levels of ROS in the sdh8Dmutant. We observed a significant
decrease in aconitase activity in sdh8D cells, consistent with an
accumulation of ROS in the mutant strain (Figure 7D). We also
established a system for measuring the redox state of yeast
mitochondria using a mitochondrially targeted redox-sensitive
GFP construct (mito-roGFP) (McFaline-Figueroa et al., 2011;
Vevea et al., 2013). This construct has been engineered to
contain two surface exposed cysteines that are capable of form-
ing a disulfide bond. Mito-roGFP exhibits two excitation peaks at
400nm and 480nm with a single emission peak at 510nm.
Oxidation of the surface-exposed cysteines promotes excitation
at 400 nm, while reduction of these residues favors excitation at
480 nm (Figures S7B and S7C) (McFaline-Figueroa et al., 2011;
Vevea et al., 2013). Thus, the excitation ratio of mito-roGFP is
a measure of the redox state of yeast mitochondria in live cells.
To quantify the redox state of the matrix, we transformed WT
cells, sdh8D cells, and sdh8D cells expressing Sdh8-His6HA3
with mito-roGFP (Figure S7D). Cells were grown in the presence
of 2% acetate and analyzed by flow cytometry. Consistent with
the aconitase activity data, we observed an increase in the ratio
of oxidized/reduced mito-roGFP in the sdh8D strain that was
fully rescued by re-expressing Sdh8-His6HA3 (Figures 7E and
7F). If this impaired growth of the sdh8D mutant is the result of
the elevated ROS seen in these cells, then overexpression of
genes involved in ROS detoxification might suppress the growth
phenotype. Consistent with this, overexpression of YAP1, a tran-
scription factor that stimulates the expression of many genes.
Figure 5. Drosophila Sdhaf4 Mutants
Display Neurodegenerative Phenotypes,
Early-Adult Lethality, and Sensitivity to
Oxidative Stress
(A) The number of surviving w1118 control
(dSdhaf4+) or dSdhaf41/2 mutant (dSdhaf4)
females maintained on standard laboratory food
at normoxia was assayed at 2–4 day intervals.
Each data point is the percentage of surviving
flies ±SEM, with at least 110 flies assayed per
genotype.
(B) Control or dSdhaf4 mutant females aged
6–8 hr, 2–4 days, or 8–12 days were vortexed for
15 s, and the percentage of paralyzed flies
was counted as described (Ganetzky and Wu,
1982). (±SEM. n > 32 flies per age per genotype.
**p < 0.01 and ***p < 0.001 [ANOVA].)
(C) The length of time required for the dSdhaf4
mutant flies in (A) to recover from paralysis is
presented as a bar graph, with the number of
paralyzed dSdhaf4 mutants analyzed from each
age group depicted above the bar.
(D) Cross-sections of compound eyes from 8- to
12-day-old control or dSdhaf4 mutant flies visual-
ized by transmission electron microscopy. Arrows
point to aberrant vesicularization of dSdhaf4
mutant photoreceptors, arrowheads point to
mitochondria, and asterisks denote vacuoles.
(E) control or dSdhaf4 mutant flies at 8–12 days of
age carrying either the ubiquitous Daughterless-
Gal4 (Da-GAL4) driver, the pan-neuronal Elav-
Gal4 driver, or no driver, in the presence or
absence of either a UAS-dSdhaf4 transgene or a
UAS-human Sdhaf4 (hSdhaf4) transgene, were
vortexed as in (A). Note that UAS-dSdhaf4 alone
has leaky dSdhaf4 activity since it partially res-
cues in the absence of a GAL4 driver. (±SEM. n =
15–40. ***p < 0.001 [ANOVA].)
(F) Control or dSdhaf4mutant females at 2–4 days
of age were transferred to 100% oxygen, and the
number of surviving animals was counted each
day. The median lifespan after transfer to hyperoxia is 9 days for controls and 1 day for dSdhaf4 mutants. Data are shown as the percentage of surviving
flies ±SEM. At least 40 flies were assayed per genotype. p values for both survival curves ([A] and [F]) were calculated using a log rank test.
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GSH1, and GLR1), as well as the mitochondrial superoxide
dismutase SOD2, completely or partially rescued the growth
phenotype of sdh8D cells (Figures 7G and S7E). Interestingly,
despite a profound ability to rescue the growth phenotype asso-
ciated with sdh8D cells, YAP1 overexpression has no effect on
SDH activity (Figure 7H), SDH assembly (Figure S7F), or Sdh2
steady-state levels (Figure S7G). Thus, we conclude that the
ability of YAP1 to rescue the sdh8D mutant phenotype is not
related to SDH activity and likely due to an amelioration of oxida-
tive stress in the mutant cells.
DISCUSSION
The critical role of SDH in primary cellular metabolism is reflected
by the variety of diseases associated with its dysfunction. Unlike
other ETC complexes, which require multiple factors for their
assembly, only two factors, SDHAF1 and SDHAF2, have been
identified to date that are required for the assembly of the SDH
holocomplex within the IMM (Ghezzi et al., 2009; Hao et al.,Cel2009). Herein we use three distinct eukaryotic model systems,
yeast, Drosophila, and mammalian cells, to demonstrate that
the SDHAF4 protein family consists of evolutionarily conserved
SDH assembly factors. We show that Sdh8 binds directly to fla-
vinated Sdh1, blocking the generation of excess ROS and facil-
itating its interaction with Sdh2 and the subsequent assembly of
the SDH holocomplex. These functions for SDHAF4 appear to
be conserved in metazoans and suggest a role for this factor in
disease, as Drosophila Sdhaf4 mutants display muscular and
neuronal dysfunction as well as neurodegeneration.
Yeast sdh8D and Drosophila Sdhaf4 mutants exhibit the
classic metabolomic phenotype of SDH deficiency, with an
apparent block in the TCA cycle that results in an accumulation
of succinate and a depletion of fumarate and malate, the two
TCA cycle intermediates downstream of SDH. Consistent with
these effects, the yeast and fly mutants display a reduction in
the steady-state levels of the SDH holocomplex and reduced
SDH enzyme activity, indicating an important role for SDHAF4
in SDH stability and activity. siRNA-mediated knockdown of
SDHAF4 in mammalian cells leads to similar defects. Moreover,l Metabolism 20, 241–252, August 5, 2014 ª2014 Elsevier Inc. 247
Figure 6. Yeast Sdh8 Is a Cochaperone for
Unbound and Covalently Flavinated Sdh1
(A) Sdh8-His6HA3 was immunoprecipitated from
digitonin-solubilized mitochondria isolated from
the yeast strains described as follows: lanes 1 and
6, WT cells; lanes 2 and 7, sdh8D cells expressing
Sdh8-His6HA3; lanes 3 and 8, sdh2D sdh8D
cells expressing Sdh8-His6HA3; lanes 4 and 9,
sdh1D sdh8D cells expressing Sdh8-His6HA3
and Sdh1H90A; and lanes 5 and 10, sdh1D
sdh2D sdh8D cells expressing Sdh8-His6HA3 and
Sdh1H90A.
(B) Mitochondrial lysates isolated from the
following strains were fractionated by SDS-PAGE.
Lane 1, sdh8D cells expressing Sdh8-His6HA3;
lane 2, sdh1D sdh8D cells expressing Sdh8-
His6HA3; lane 3, sdh2D sdh8D cells expressing
Sdh8-His6HA3; lane 4, sdh8D cells; lane 5, sdh2D
sdh8D cells (BY4741 background). Steady-state
protein abundance was assessed by immunoblot
using antibodies against Sdh1, Sdh2, and HA
(Sdh8-His6HA3).
(C) Mitochondria isolated from the following yeast
strains were solubilized in digitonin and fraction-
ated by BN-PAGE: lane 1, sdh8D cells expressing
Sdh8-His6HA3; lane 2, sdh2D sdh8D cells expressing Sdh8-His6HA3; lane 3, sdh1D sdh2D sdh8D cells expressing Sdh8-His6HA3; lane 4, sdh2D sdh8D; lane 5,
sdh4D sdh8D cells expressing Sdh8-His6HA3; lane 6, sdh1D sdh4D sdh8D cells expressing Sdh8-His6HA3; and lane 7, sdh4D sdh8D cells. Immunoblotting was
used to detect Atp2 (complex V) as a control and complexes containing Sdh1, Sdh2, and HA (Sdh8-His6HA3). SDH complex (232 kDa), Sdh1-Sdh8 subcomplex
(150 kDa).
Cell Metabolism
SDHAF4 Functions as an SDH Assembly Factorexpression of either fly or human SDHAF4 is sufficient to rescue
the growth defects of an sdh8D mutant yeast strain. Taken
together, these results demonstrate that the central requirement
for SDHAF4 in SDH assembly has been conserved through evo-
lution, from yeast to mammals.
Our biochemical studies in yeast provide a mechanistic
context for understanding the role of SDHAF4 in SDH assembly.
An unbiased proteomic analysis of Sdh8-associated proteins
revealed a physical interaction between Sdh8 and Sdh1, the
catalytic subunit of SDH. We confirmed the specificity of this
interaction by coimmunoprecipitation and demonstrated that
an Sdh1-Sdh8 subcomplex of 150 kDa can be detected in
unstressed WT cells, albeit at very low levels. Increased levels
of this subcomplex, however, become readily detectable upon
genetic disruption of the SDH complex through deletion of either
Sdh2 or Sdh4. Taken together, these results support the model
that Sdh8 interacts with a soluble pool of Sdh1 prior to the for-
mation of the Sdh1-Sdh2 soluble dimer and assembly of the
holocomplex. Moreover, Sdh8 interacts specifically with the fla-
vinated form of Sdh1, indicating that this association follows
Sdh1 flavination by Sdh5/SDHAF2 (Hao et al., 2009). This model
is consistent with the localization of Sdh8 to the matrix where
it can readily access free flavo-Sdh1, which is subsequently
tethered to the IMM through its association with Sdh2 and the
membrane-bound Sdh3/Sdh4 dimer.
We observed that Sdh8 stability directly relates to its asso-
ciation with Sdh1, further supporting the centrality of its role
as an Sdh1 chaperone. Thus, deletion of Sdh1 leads to a dra-
matic reduction in Sdh8 levels while deletion of Sdh2, which
causes greatly increased availability of free Sdh1, leads to an in-
crease in Sdh8. Although Sdh1 protein levels are unperturbed
in sdh8D cells, we observed considerable destabilization of248 Cell Metabolism 20, 241–252, August 5, 2014 ª2014 Elsevier IncSdh2, which is consistent with impaired formation of Sdh1-
Sdh2 dimers. Therefore, we hypothesize that the occupation of
free Sdh1 by Sdh8 facilitates the formation of Sdh1-Sdh2
dimers. This dimer fails to form efficiently in the absence of
Sdh8, and Sdh2 is destabilized as it is in mutants lacking Sdh1
altogether.
Interestingly, the loss of SDHAF4 appears to havemore severe
consequences in Drosophila than in yeast or mammalian cells.
dSdhaf4 mutants display a profound reduction in SDH enzyme
activity, destabilization of both SdhA and SdhB, and a significant
loss of SDH holocomplexes. In contrast, yeast sdh8D mutants
and C2C12 mouse myoblasts treated with SDHAF4 siRNA
maintain 40%–50% of WT SDH activity and preserve a similar
fraction of assembled SDH holocomplexes. While yeast sdh8D
mutants have relatively normal levels of Sdh1, dSdhaf4 mutants
have greatly reduced levels of SdhA, which probably underlies
the nearly complete loss of SDH holocomplexes. It is possible
that yeast and mammalian cells express an additional SDHA
chaperone that can function in the absence of SDHAF4, main-
taining the levels of SDHA to support holocomplex assembly. It
is also possible that growth in rich culture medium provides a
buffer against oxidative stress in yeast that is not present in the
more complex Drosophila system. Identification of the mecha-
nism that underlies this discrepancy, however, will require further
study of SDH assembly in both yeast and flies. Regardless, it is
important to note that dSdhaf4mutants retain some SDH activity
(15%) and that this is sufficient to support limited viability,
albeit with both muscular (erect wings) and behavioral (neuro-
degeneration) dysfunction. In contrast, SdhA null mutants are
lethal, demonstrating that a further reduction in SDH activity
cannot be tolerated (Mast et al., 2008). Thus, while the SDHAF4
protein family is clearly involved in SDH stability and activity, it.
Figure 7. Sdh8 Protects the Cell from
Oxidative Stress
(A) Ten-fold serial dilutions of WT and sdh8D
yeast either transformed with an empty vector
or overexpressing Sdh1 were plated on media
containing the indicated carbon source (W303
background).
(B) Ten-fold serial dilutions of WT yeast trans-
formed with an empty vector, WT yeast over-
expressing Sdh1, and WT yeast overexpressing
Sdh1 and Sdh8-His6HA3 were plated on media
containing acetate (W303 background).
(C) Ten-fold serial dilutions of WT yeast trans-
formed with an empty vector, sdh8D cells trans-
formed with an empty vector, and sdh8D cells
expressing Sdh8-His6HA3 were plated on media
containing glycerol with and without 1 mM para-
quat and incubated at 30C (W303 background)
as in (A).
(D) Aconitase activity was measured in WT and
sdh8D cells grown to stationary phase in syn-
thetic complete media containing 2% glucose and
normalized to total protein (±SEM; n =4 biological
replicates. **p < 0.005).
(E) WT cells (solid line), sdh8D cells (dashed
line), and sdh8D cells expressing Sdh8-His6HA3
(dotted line) transformed with mito-roGFP
were plated on synthetic media containing 2%
acetate, allowed to grow for 48 hr, and analyzed
by flow cytometry. Shown are representative
histograms measuring the ratio of oxidized/
reduced mito-roGFP in 30,000 cells (BY4741
background).
(F) The median value of the ratio of oxidized/
reduced mito-roGFP is plotted for WT cells,
sdh8D cells, and sdh8D cells expressing Sdh8-
His6HA3 (±SEM; n = 4 biological replicates. ****p <
0.0001).
(G) Ten-fold serial dilutions of WT yeast
transformed with an empty vector, sdh8D cells
transformed with an empty vector, and sdh8D cells overexpressing YAP1 were plated on media containing the indicated carbon source and incubated
at 30C (BY4741 background) as in (A).
(H) SDH activity enzyme assays were performed using mitochondria harvested from WT and sdh8D cells carrying an empty vector or overexpressing YAP1.
Activity was normalized to total protein (±SEM; n = 3 biological replicates. **p < 0.005).
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SDH activity remains in the absence of the respective SDHAF4
ortholog in all three model systems.
Our demonstration that Sdh8 acts through Sdh1 to facilitate
formation of the Sdh1/Sdh2 dimer, and subsequently the SDH
holocomplex, further emphasizes the importance of dedicated
chaperones for ETC complex assembly. We propose that this
unique demand might relate to the need to protect the redox-
active cofactors present in many ETC complex subunits (Mess-
ner and Imlay, 2002). Prior to assembly, these cofactors are
exposed to solvent and are, therefore, susceptible to damaging
chemical reactions. The susceptibility of free cofactors to
damaging chemical reactions is exemplified by our data sug-
gesting that free flavinated Sdh1 is toxic and that this toxicity
is alleviated by Sdh8. Overexpression of Sdh1 causes growth
defects in WT cells, but this phenotype is exacerbated in
sdh8D mutants and ameliorated by co-overexpression of
Sdh8. Thus, we conclude that the chaperone activity of Sdh8
protects the cell from potentially damaging effects of unboundCelSdh1, which are likely due to the generation of ROS enabled
by solvent-accessible FAD. Sdh1, which contains a covalently
bound, redox active, FAD cofactor is capable of oxidizing succi-
nate to fumarate independent of the SDH complex. This oxida-
tion of succinate leads to the reduction of FAD, which is then
auto-oxidized bymolecular oxygen to yield superoxide (Messner
and Imlay, 2002; Guzy et al., 2008). The observation that Sdh8
interacts specifically with covalently flavinated Sdh1, but not
with apo-Sdh1, is consistent with Sdh8 acting to prevent this
mechanism of oxidative stress. Further, sdh8D mutant cells
were unable to grow on respiratory medium in the presence of
the superoxide producer paraquat and demonstrate a marked
accumulation of ROS as determined by two independent assays.
Similarly, dSdhaf4 mutant flies are highly sensitive to oxidative
stress induced by hyperoxia. Importantly, overexpression of
two genes involved in the detoxification of ROS —YAP1 and
SOD2—rescued the sdh8D growth defects in yeast without
affecting the SDH activity, SDH assembly, or steady-state
Sdh2 levels. We conclude that, in addition to promotingl Metabolism 20, 241–252, August 5, 2014 ª2014 Elsevier Inc. 249
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redox-active FAD cofactor from potentially deleterious solvent
interactions.
These biochemical aberrations resulted in profound physio-
logical defects in Drosophila lacking dSdhaf4, all of which are
hallmarks of mitochondrial dysfunction and which suggest
possible links to human disease. Most notably, dSdhaf4mutants
display bang sensitivity, a phenotype characterized by a sus-
ceptibility to mechanically induced paralytic seizures, which is
commonly elicited by defects in mitochondrial function (Ferges-
tad et al., 2006; Liu et al., 2007). dSdhaf4 mutants also display
neurodegeneration and reduced lifespan, which often accom-
pany bang sensitivity (Fergestad et al., 2008). In addition, we
observed abnormal wing posture in dSdhaf4 mutants, which is
characteristic of muscular dysfunction (Greene et al., 2003).
Similar phenotypes have been reported in flies harboring muta-
tions in several known disease-causing genes that impact mito-
chondrial function. For example, Pink and Parkinmutants display
abnormal wing posture, andmtATP6mutants are bang sensitive
(Celotto et al., 2006b; Fernandes and Rao, 2011). Human muta-
tions in Pink/Parkin and mtATP6 are known to cause familial
Parkinson’s disease andmitochondrial encephalopathy, respec-
tively (Schapira, 2012). Moreover, as described in more detail
below, some neurodegenerative diseases such as Leigh’s syn-
drome are known to be associated with a loss of SDH activity.
Our studies of dSdhaf4 thus provide a genetic model for better
understanding the pathophysiology of neurodegenerative disor-
ders that are caused by SDH deficiency (Rutter et al., 2010;
Hoekstra and Bayley, 2013).
Similar to dSdhaf4 mutants, SdhB hypomorphic mutants that
retain 40% of normal SDH activity are sensitive to oxidative
stress and display a reduced lifespan (Walker et al., 2006). The
SdhB hypomorphs, however, were not reported to undergo
mechanically induced paralytic seizures or display neurodegen-
erative phenotypes (Walker et al., 2006). This lack of neuronal
phenotypes in SdhB mutants could be due to the higher overall
SDH activity seen in these partial loss-of-function mutants rela-
tive to a complete loss of dSdhaf4 activity. It is also possible,
however, that the neurodegeneration phenotype is driven by
increased ROS production rather than a defect in mitochondrial
ATP production. In support of this model, clones generated us-
ing a lethal null allele of SdhA in the eye display retinal degener-
ation similar to that seen in dSdhaf4 mutants, which was shown
to be specifically caused by increased ROS production (Mast
et al., 2008). This is also consistent with our finding that dSdhaf4
mutants are not depleted of ATP, possibly enabled by metabolic
compensation (Celotto et al., 2011). Thus, our study of dSdhaf4,
and other work characterizing SdhA, SdhB, and dSdhaf3 mu-
tants in Drosophila, suggests that tissue dysfunction induced
by a loss of SDH appears to be largely driven by increased
ROS production. This is consistent with our hypothesis that
SDH assembly factors may have evolved as a mechanism to
protect cells and organisms from ROS production during SDH
assembly.
Mutations in all genes encoding previously published SDH
subunits and assembly factors have been shown to cause
human disease. These include neurodegenerative diseases
(Leigh’s Syndrome, leukodystrophy, and leukoencephalopathy),
which have been linked to mutations in SDHA, SDHB, and250 Cell Metabolism 20, 241–252, August 5, 2014 ª2014 Elsevier IncSDHAF1 (Horva´th et al., 2006; Ghezzi et al., 2009; Alston et al.,
2012; Ohlenbusch et al., 2012). Mutations in SDHA, SDHB,
SDHC, SDHD, and SDHAF2 have also been shown to cause par-
agangliomas and pheochromocytomas—two classes of neuro-
endocrine tumors (Astuti et al., 2001; Hao et al., 2009; Fishbein
and Nathanson, 2012). Recently, several cases of WT gastroin-
testinal stromal tumors (WT GIST) have been linked to germline
loss-of-function mutations in SDHA and SDHB (Janeway et al.,
2011; Celestino et al., 2012; Italiano et al., 2012; Oudijk et al.,
2013). This wealth of evidence linking SDH dysfunction to dis-
ease raises the possibility that damaging mutations in SDHAF4
may cause human disease. In fact, several cases of SDH-defi-
cient diseases, including Leigh’s Syndrome and WT GIST,
lack mutations in the genes encoding all known SDH subunits
(Horva´th et al., 2006; Janeway et al., 2011; Jain-Ghai et al.,
2013). Our phenotypic studies raise the important possibility
that SDHAF4 is a candidate gene for these and other dis-
eases characterized by SDH deficiency. Our future efforts will
focus on determining the incidence of these possible causative
SDHAF4 mutations.
On the basis of the data presented in this report, we conclude
that the SDHAF4 gene family encodes an SDH assembly factor.
Insights gained in our studies of this protein have allowed us to
propose a more complete model of SDH assembly (Figure S7H).
Upon import into the matrix by TOM and TIM, apo-Sdh1 is flavi-
nated in a reaction that requires Sdh5 (Hao et al., 2009). Free
flavo-Sdh1 is then bound by Sdh8 to form a 150 kDa sub-
complex. This subcomplex occupies Sdh1, preventing auto-
oxidation and supporting its ability to dimerize with Sdh2. The
Sdh1-Sdh2 soluble dimer is then recruited to the IMMvia interac-
tions with Sdh3 and Sdh4 to form the SDH holocomplex. This
model highlights the importance of subunit-specific chaperones
in the process of assembly. Indeed, failure of SDHAF4 to occupy
free SdhA prevents normal SDH assembly in three eukaryotic
systems and has profound physiological consequences. The
identification and characterization of the SDHAF4 protein family
thus provides important new insights into the process of SDH as-
sembly, the mechanisms by which SDH subunits are protected
for generating ROS, and a new candidate gene to understand
human disease associated with a loss of SDH activity.EXPERIMENTAL PROCEDURES
Drosophila Metabolomic Analysis and Enzyme Activity Assays
Adult male flies were aged 5–7 days, washed with PBS, and snap frozen
in liquid nitrogen. Metabolites were extracted from frozen flies, and gas chro-
matography-mass spectrometry (GC/MS) was performed as previously
described (Bricker et al., 2012). SDH activity was measured in mitochondrial
extracts, as previously described, by examining the reduction of iodonitrote-
trazolium at 500 nm in the presence of succinate (Celotto et al., 2011). CS
activity was measured in mitochondrial extracts by examining the reduction
of 5,50-5 dithiobis-2-nitrobenzoic acid in the presence of oxaloacetate and
acetyl-CoA, as previously described (Tang et al., 2009). Enzyme activity per
gram of mitochondrial protein was calculated.
Drosophila Paralytic Assays
Bang sensitivity was measured as previously described (Ganetzky and Wu,
1982). Flies were collected in groups of five to eight females per vial and
allowed to recover from CO2 anesthesia for at least 2 hr. Flies were then vor-
texed for 15 s, and the time it takes to return to a standing position was as-
sayed. At least three vials were assayed per condition in each experiment,.
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are presented, but similar results were observed when assaying males (data
not shown).
Electron Microscopy
Heads were removed from 8- to 12-day-old female flies, the proboscis was
removed, and EM was performed as described in the Supplemental Experi-
mental Procedures.
Mito-roGFP and Flow Cytometry
The protocol used in this investigation has been adapted from Vevea et al.,
2013. For each experiment, an equal number of cells transformed with mito-
roGFP were plated thinly on synthetic media containing 2% acetate or
2% glycerol. Cells were allowed to incubate for approximately 48 hr before
being harvested and analyzed by flow cytometry. Data was collected at the
University of Utah Flow Cytometry Core Facility. Cells were acquired on a
BD FACSCanto II by collecting emission wavelengths of 530/30 from a violet
(405 nm) and blue (488 nm) laser. Postacquisition analysis was accomplished
in Flowjo (Treestar, Inc). After single cells were selected using FSC-W and
FSC-H parameters, GFP+ cells were gated on for further analysis. The fluores-
cence intensity was expressed as a ratio of oxidized (405 nm excitation) to
reduced (488 nm excitation) mito-roGFP.
BN-PAGE
BN-PAGE was performed as described previously (Wittig et al., 2006). Mito-
chondria were resuspended in lysis buffer (50mMNaCl, 5mM 6-aminocaproic
acid, 50 mM imidazole, 1 mM AEBSF, and protease inhibitor cocktail). Yeast
and Drosophilamitochondria were solubilized with 1% digitonin and mamma-
lian mitochondria with 2% digitonin. Lysates were resolved on a 3%–13%
gradient native gel using a PROTEAN II xi Cell gel running system (Bio-Rad).
Western blot performed as described elsewhere using a Trans-blot transfer
cell (Bio-Rad) and PVDF membranes.
Statistics
PRISM software was used to graph all quantitative data and perform statistical
analyses. p values for pairwise comparisons were determined using a Stu-
dent’s t test, and p values for multiple comparisons were calculated using
one-way ANOVA with a Bonferroni correction. Metabolomics data are pre-
sented in box-plot form, where the box represents the 25th–75th percentile,
the line is the median, and the whiskers represent the range of the data. All
other quantitative data are shown as the mean ±SEM. p values for Kaplan-Me-
ier survival curves in Figures 5 and S5 were calculated using a log rank test.
SUPPLEMENTAL INFORMATION
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